The global cervical cancer treatment market attained a value of USD 7.24 billion in 2023. The market is expected to grow further at a CAGR of 6.4% during the forecast period of 2024-2032 to attain a value of USD 12.65 billion by 2032, driven by the rising prevalence of the disease across the globe.